Alto Neuroscience, Stock Target Price and Analyst Consensus
| ANRO Stock | 2.27 0.14 5.81% |
The current analyst and expert consensus on Alto Neuroscience, is Strong Buy, with 6 strong buy opinions. The current projected Alto Neuroscience, target price consensus is 12.72 with 7 analyst opinions. Check out Macroaxis Advice on Alto Neuroscience, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.The most common way Alto Neuroscience, analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Alto Neuroscience, executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Alto Neuroscience,. We strongly encourage you to use your own analysis of Alto Neuroscience, to validate this buy or sell advice. Alto Neuroscience, buy-or-sell recommendation module provides average expert sentiment on the projected Alto Neuroscience, target price to derive its highest and lowest estimates based on projected price volatility of 5.1198.
Lowest Forecast 11.58 | Highest Forecast 14.12 | Target Price 12.72 |
Alto |
It's important to approach Alto Neuroscience,'s target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Alto Neuroscience, Target Price Consensus
Alto target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Alto Neuroscience,'s target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Alto analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Alto stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Alto Neuroscience,, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAlto Neuroscience, Target Price Projection
Alto Neuroscience,'s current and average target prices are 2.27 and 12.72, respectively. The current price of Alto Neuroscience, is the price at which Alto Neuroscience, is currently trading. On the other hand, Alto Neuroscience,'s target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Alto Neuroscience, Market Quote on 29th of March 2025
Target Price
Analyst Consensus On Alto Neuroscience, Target Price
Alto Neuroscience, Analyst Ratings
Alto Neuroscience,'s analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Alto Neuroscience, stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Alto Neuroscience,'s financials, market performance, and future outlook by experienced professionals. Alto Neuroscience,'s historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Alto Neuroscience, price targets
Alto Neuroscience,'s stock target price is an estimate of its future price, usually made by analysts. Using Alto Neuroscience,'s target price to determine if it is a suitable investment can be done through the following steps:- Look at Alto Neuroscience,'s target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Alto Neuroscience,'s stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Alto Neuroscience, Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Alto Neuroscience, is a key component of Alto Neuroscience, valuation and have some predictive power on the future returns of a Alto Neuroscience,.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Compulsion Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Gold and Gold Mining Invested over 100 shares | |
 | Power Assets Invested over 300 shares | |
 | Video Games Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Business Services Invested few shares | |
 | Momentum Invested over 300 shares | |
 | Hedge Favorites Invested over 60 shares | |
Check out Macroaxis Advice on Alto Neuroscience, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.